A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D.

Authors

Kanwal Raghav

Kanwal Pratap Singh Raghav

The University of Texas MD Anderson Cancer Center, Houston, TX

Kanwal Pratap Singh Raghav , Lianchun Xiao , Courtney Lewis , Brittany E Zeller , Michael J. Overman , Ryan W Huey , Arvind Dasari , Kyle Chang , Katie Quinn , John Paul Y.C. Shen , Christine Megerdichian Parseghian , Jason Willis , Kaysia Ludford , Van K. Morris II, Robert A. Wolff , Xin Shelley Wang , Leylah Drusbosky , Scott Kopetz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT03844620

Citation

J Clin Oncol 42, 2024 (suppl 17; abstr LBA3557)

DOI

10.1200/JCO.2024.42.17_suppl.LBA3557

Abstract #

LBA3557

Poster Bd #

220

Abstract Disclosures

Similar Posters

First Author: Celine Yeh

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).

Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).

First Author: Mohammad A. Zeineddine

First Author: Christine Megerdichian Parseghian

First Author: Arielle Yablonovitch